NCT06054633View on ClinicalTrials.gov

L-arginine for Knee Osteoarthritis Patients

NARecruitingINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

March 20, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Osteoarthritis, Knee
Interventions
DIETARY_SUPPLEMENT

L-arginine tablet

L-arginine, 2 g, three times daily, for 12 weeks

DIETARY_SUPPLEMENT

Placebo tablet

Identical inert placebo, three times daily, for 12 weeks

Trial Locations (1)

410008

RECRUITING

Xiangya Hospital, Changsha

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

collaborator

School of Medicine, University of Nottingham

UNKNOWN

collaborator

Memorial University of Newfoundland

OTHER

lead

Xiangya Hospital of Central South University

OTHER